Navigation Links
Altogen Labs Announces Patent Filing for Bioremediation Process and Oil Spill Cleanup Products
Date:10/26/2012

AUSTIN, Texas, Oct. 26, 2012 /PRNewswire/ -- Altogen Labs announced the filing of a patent for bioremediation microorganism isolation and selection methods (USPTO application 13/490,508). This environmental technology is based on isolation of naturally present microorganisms in heavily contaminated soil, which allows accelerating natural bioremediation processes. We don't have to wait hundreds of years for nature to degrade an oil spill or clean up land contaminated with toxic chemicals and carcinogens. Instead, by reintroducing natural bacteria to oil spill sites, Altogen Labs accomplish oil degradation process in just a few months. This bioaugmentation platform technology to remediate crude oil and chemical spills can be applied worldwide.

Both laboratory and field tests showed that Altogen Labs site-specific bacterial strains are highly effective for remediation of crude oil- and petroleum-saturated earth. The bacteria is grown in the lab to speed up the natural process and then re-introduced to the contaminated site. Multiple lab studies show that after consuming the oil and having no remaining food source, the bacteria die. No adverse effects of using the live bacteria have been observed, and the effectiveness and safety of the method are remarkable. Scientists at Altogen Labs used functional genomics to perform whole genome sequencing study to characterize these newly identified natural microorganisms and identify specific biosurfactant and quorum-sensing genes that allow the microorganisms to work together for efficient and effective crude oil spill bioremediation.

Altogen Labs also offers soil remediation services and development programs focused on other chemical contaminations besides crude oil, including remediation of soil with recalcitrant organic chemical spills including polycyclic aromatic hydrocarbons, petroleum, pesticides, herbicides, perchlorate, carbon tetrachloride, chloroform, acetone, benzene, toluene, xylenes, perchloroethylene, chlorofluorocarbon, aliphatic chlorinated hydrocarbons, and other industrial and chemical manufacturing wastes and spills.

Altogen Labs announced that site-specific bioremediation products will be manufactured and sold through its exclusive distributor - Soil Bioremediation Inc (www.soil-bio-remediation.com) located in Austin, Texas.

About Altogen Labs

Altogen Labs (www.altogenlabs.com) is GLP compliant laboratory that provides biotechnology research services and biology CRO services to pharmaceutical, biotechnology, and academic institutions worldwide. Bioremediation is one of the company's focus areas. This bioaugmentation-based soil remediation technology provides conversion of toxic, environment-contaminating compounds into innocuous substances by using natural oil-degrading bacteria.

Contact
Altogen Labs
4020 South Industrial Dr, Suite 130
Austin TX 78744 USA
(512) 433-6177
Web: www.altogenlabs.com
E-mail: info@altogenlabs.com


'/>"/>
SOURCE Altogen Labs
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
5. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
6. WuXi PharmaTech Announces Third-Quarter 2011 Results
7. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
8. Spherix Announces Third Quarter Financial Results
9. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
10. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
11. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 03, 2016 , ... ... clinics and IVF laboratories. A contingency of reproductive endocrinologists, including Dr. George ... women experiencing infertility and to help them build families. , Ovation Fertility is ...
(Date:5/2/2016)... CA (PRWEB) , ... May 02, 2016 , ... StarNet ... solutions today announced the addition of three Secure Remote Desktop modules to its flagship ... remote desktops from Linux and Unix servers to the user’s PC over encrypted SSH. ...
(Date:4/29/2016)... ... April 29, 2016 , ... Proove ... excited to announce the launch of the Proove Health Foundation . The ... education to promote the use of personalized medicine for tackling the nation’s most-pressing ...
(Date:4/29/2016)... CO (PRWEB) , ... April 29, 2016 , ... ... addressing the necessary fundamentals to transform technology into a viable company, CereScan’s CEO, ... growth. Mr. Kelley, a recognized leader and mentor in the Denver area ...
Breaking Biology Technology:
(Date:3/11/2016)... -- --> --> ... Market by Technology (Pattern Recognition), by Component (Hardware, Software, ... (On-Premises and Cloud), by Industry Vertical and by Region ... global market is expected to grow from USD 12.49 ... at a CAGR of 19.1%. , ...
(Date:3/9/2016)... This BCC Research report provides an overview ... Sequencing (RNA Seq) market for the years 2015, 2016 ... reagents, data analysis, and services. Use this ... market such as RNA-Sequencing tools and reagents, RNA-Sequencing data ... each segment and forecast their market growth, future trends ...
(Date:3/8/2016)...   Valencell , the leading innovator in ... secured $11M in Series D financing. The investment ... fund being launched by UAE-based financial services company ... TDF Ventures and WSJ Joshua Fund. Valencell plans ... growth and accelerate its pioneering innovation in accurate ...
Breaking Biology News(10 mins):